Novartis CEO ‘very confident’ on sales target, doesn’t fear patent cliff – newspaper
ZURICH (Reuters) – Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant having nothing to fear from the end of patent protection on some drugs. “I am very confident that we will achieve average growth…